Carey R, Damianopoulos E, De Palma G
VA Medical Center, Syracuse, NY 13210, USA.
Pharmacol Biochem Behav. 2000 Aug;66(4):863-72. doi: 10.1016/s0091-3057(00)00290-2.
In the first experiment, separate groups of rats (n = 7) were treated with either saline, cocaine (10 mg/kg), haloperidol (0.1 mg/kg), or cocaine (10 mg/kg) plus haloperidol (0.1 mg/kg). Locomotor behavior was measured in an open-field environment, and cocaine induced a reliable locomotor stimulant effect compared to saline-treated animals. Haloperidol produced a progressive decline in locomotion over the 5 test days. Haloperidol also blocked cocaine stimulant effects compared to cocaine-treated animals. In the second experiment, five groups (n = 7) of animals were treated either with saline, cocaine (10 mg/kg), 8-OH DPAT (0.2 mg/kg), 8-OH DPAT (0.2 mg/kg) plus haloperidol (0.1 mg/kg), or 8-OH DPAT (0.2 mg/kg) plus haloperidol 0.1 mg/kg plus cocaine (10 mg/kg). Over the course of 5 days of treatment, cocaine induced a locomotor stimulant effect. Saline and 8-OH DPAT animals did not differ in terms of locomotion. The 0.1 mg/kg haloperidol plus 0.2 mg/kg 8-OH DPAT treatment decreased locomotion compared to the saline group, but the group given 0.2 mg/kg 8-OH DPAT plus 0.1 mg/kg haloperidol plus cocaine (10 mg/kg) exhibited a locomotor stimulant effect equivalent to the cocaine group. In a third experiment, it was found that the 0.2 mg/kg 8-OH DPAT treatment did not enhance the locomotor stimulant effect of cocaine. Thus, the 8-OH DPAT treatment was able to restore a cocaine locomotor stimulant effect in animals treated with haloperidol without directly enhancing the locomotor stimulant effects of cocaine. In Experiments 2 and 3, entries into the central zone of the open field were measured. Cocaine reliably increased central zone entries. The 8-OH DPAT treatment, however, selectively blocked this behavioral effect of cocaine suggesting a qualitative influence of 5-HT(1A) receptors upon cocaine, independent of locomotion activation by cocaine. Ex vivo measurements of dopamine and 5-hydroxytryptamine metabolism in limbic tissue were consistent with the established effects of cocaine, haloperidol, and 8-OH DPAT upon dopamine and 5-hydroxytryptamine neurotransmission. In addition, measurement of cocaine brain concentration indicated that neither haloperidol or 8-OH DPAT affected cocaine concentration in brain.
在第一个实验中,将几组大鼠(每组n = 7)分别用生理盐水、可卡因(10毫克/千克)、氟哌啶醇(0.1毫克/千克)或可卡因(10毫克/千克)加氟哌啶醇(0.1毫克/千克)进行处理。在开放场地环境中测量运动行为,与用生理盐水处理的动物相比,可卡因诱导出可靠的运动兴奋效应。氟哌啶醇在5天的测试期内使运动能力逐渐下降。与用可卡因处理的动物相比,氟哌啶醇也阻断了可卡因的兴奋效应。在第二个实验中,五组(每组n = 7)动物分别用生理盐水、可卡因(10毫克/千克)、8-羟基二丙胺基四氢萘(8-OH DPAT,0.2毫克/千克)、8-OH DPAT(0.2毫克/千克)加氟哌啶醇(0.1毫克/千克)或8-OH DPAT(0.2毫克/千克)加氟哌啶醇0.1毫克/千克加可卡因(10毫克/千克)进行处理。在5天的治疗过程中,可卡因诱导出运动兴奋效应。生理盐水组和8-OH DPAT组动物在运动方面没有差异。与生理盐水组相比,0.1毫克/千克氟哌啶醇加0.2毫克/千克8-OH DPAT的处理使运动能力下降,但给予0.2毫克/千克8-OH DPAT加0.1毫克/千克氟哌啶醇加可卡因(10毫克/千克)的组表现出与可卡因组相当的运动兴奋效应。在第三个实验中,发现0.2毫克/千克8-OH DPAT的处理并未增强可卡因的运动兴奋效应。因此,8-OH DPAT处理能够在氟哌啶醇处理的动物中恢复可卡因的运动兴奋效应,而不会直接增强可卡因的运动兴奋效应。在实验2和3中,测量了进入开放场地中央区域的次数。可卡因可靠地增加了进入中央区域的次数。然而,8-OH DPAT处理选择性地阻断了可卡因的这种行为效应,表明5-羟色胺(5-HT)1A受体对可卡因有定性影响,与可卡因激活运动无关。对边缘组织中多巴胺和5-羟色胺代谢的体外测量结果与可卡因、氟哌啶醇和8-OH DPAT对多巴胺和5-羟色胺神经传递的既定效应一致。此外,可卡因脑浓度的测量表明,氟哌啶醇和8-OH DPAT均未影响脑中的可卡因浓度。